Anti‐A and SARS‐CoV‐2: an intriguing association (2021)
- Authors:
- Dutra, Valeria de Freitas
- Bub, Carolina Bonet
- Yokoyama, Ana Paula Hitomi
- Achkar, Ruth
- Machado, Rafael Rahal Guaragna
- Assunção, Murilo
- Candelelaria, Gabriela
- Soares, Camila Pereira
- Fachini, Roberta Maria
- Wendel, Rita Fontão
- Hamerschlak, Nelson
- Reis, Luiz Fernando Lima
- Araujo, Danielle Bastos
- Nudelman, Victor
- Pinho, João R. R.
- Rizzo, Luiz Vicente
- Sakashita, Araci M.
- Scuracchio, Patrícia
- Durigon, Edison Luiz
- Wendel, Silvano
- Kutner, José Mauro
- Dutra, Valeria de Freitas
- USP affiliated authors: DURIGON, EDISON LUIZ - ICB ; MACHADO, RAFAEL RAHAL GUARAGNA - ICB ; SOARES, CAMILA PEREIRA - ICB
- Unidade: ICB
- DOI: 10.1111/vox.13044
- Subjects: MICROBIOLOGIA; COVID-19; GRUPOS SANGUÍNEOS; INFECÇÕES POR CORONAVIRUS; PLASMA; REAÇÃO EM CADEIA POR POLIMERASE; IMUNOGLOBULINAS; ESTUDOS DE COORTES; ESTUDOS RETROSPECTIVOS
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Publisher: Wiley-Blackwell Publishing Ltd
- Publisher place: Chichester
- Date published: 2021
- Source:
- Título: Vox Sanguinis
- ISSN: 1423-0410
- Volume/Número/Paginação/Ano: 7 p., 2021
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: green
-
ABNT
DUTRA, Valeria de Freitas et al. Anti‐A and SARS‐CoV‐2: an intriguing association. Vox Sanguinis, p. 7 , 2021Tradução . . Disponível em: https://doi.org/10.1111/vox.13044. Acesso em: 27 dez. 2025. -
APA
Dutra, V. de F., Bub, C. B., Yokoyama, A. P. H., Achkar, R., Machado, R. R. G., Assunção, M., et al. (2021). Anti‐A and SARS‐CoV‐2: an intriguing association. Vox Sanguinis, 7 . doi:10.1111/vox.13044 -
NLM
Dutra V de F, Bub CB, Yokoyama APH, Achkar R, Machado RRG, Assunção M, Candelelaria G, Soares CP, Fachini RM, Wendel RF, Hamerschlak N, Reis LFL, Araujo DB, Nudelman V, Pinho JRR, Rizzo LV, Sakashita AM, Scuracchio P, Durigon EL, Wendel S, Kutner JM. Anti‐A and SARS‐CoV‐2: an intriguing association [Internet]. Vox Sanguinis. 2021 ;7 .[citado 2025 dez. 27 ] Available from: https://doi.org/10.1111/vox.13044 -
Vancouver
Dutra V de F, Bub CB, Yokoyama APH, Achkar R, Machado RRG, Assunção M, Candelelaria G, Soares CP, Fachini RM, Wendel RF, Hamerschlak N, Reis LFL, Araujo DB, Nudelman V, Pinho JRR, Rizzo LV, Sakashita AM, Scuracchio P, Durigon EL, Wendel S, Kutner JM. Anti‐A and SARS‐CoV‐2: an intriguing association [Internet]. Vox Sanguinis. 2021 ;7 .[citado 2025 dez. 27 ] Available from: https://doi.org/10.1111/vox.13044 - A longitudinal study of convalescent plasma (CCP) donors and correlation of ABO group, initial neutralizing antibodies (nAb), and body mass index (BMI) with nAb and anti‐nucleocapsid (NP) SARS‐CoV‐2 antibody kinetics: proposals for better quality of CCP collections
- Surrogate test performance for SARS-CoV-2 neutralizing antibodies (nAbs) for convalescent plasma (CCP): how useful could they be?
- Development and validation of an enzyme-linked immunoassay kit for diagnosis and surveillance of COVID-19
- Cross-lineage protection between chikv primary infection and mayv secondary exposure in mice
- Convalescent plasma for COVID-19 in hospitalised patients: an open-label, randomised clinical trial
- Screening for SARS‐CoV‐2 antibodies in convalescent plasma in Brazil: preliminary lessons from a voluntary convalescent donor program
- SARS-CoV-2 rapid antigen test based on a new anti-nucleocapsid protein monoclonal antibody: development and real-time validation
- Heterogeneous development of children with congenital Zika Syndrome-associated microcephaly
- Nebulized enriched heparin improves respiratory parameters in patients with COVID-19: a phase I/II randomized and triple-blind clinical trial
- Nebulized enriched heparin to treat no critical patients with Sars-Cov-2: triple-blind clinical trial
Informações sobre o DOI: 10.1111/vox.13044 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
